The Hidden Cost of Control: Rethinking Oversight in Clinical Development

Session details:

As clinical development grows more complex, sponsors have responded by layering on governance, metrics, reporting, and oversight to reduce risk. But are these controls truly driving value—or introducing new friction?

This session addresses:

• Identifying governance layers that slow decision-making and execution

• Rethinking risk management frameworks to move towards proactive, data-driven approaches

• Empowering CROs, sites, and partners while maintaining standards
• Designing leaner operating models to reduce reporting burden and duplicative processes across stakeholders